Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Amortizatization of Intangibles (2016 - 2025)

Cytosorbents (CTSO) has disclosed Amortizatization of Intangibles for 13 consecutive years, with -$272000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles fell 691.3% year-over-year to -$272000.0, compared with a TTM value of $235702.0 through Sep 2025, down 56.03%, and an annual FY2024 reading of $264702.0, down 53.1% over the prior year.
  • Amortizatization of Intangibles was -$272000.0 for Q3 2025 at Cytosorbents, down from $190635.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $398035.0 in Q4 2021 and bottomed at -$272000.0 in Q3 2025.
  • Average Amortizatization of Intangibles over 5 years is $99068.8, with a median of $59982.0 recorded in 2022.
  • The sharpest move saw Amortizatization of Intangibles surged 617.94% in 2023, then crashed 691.3% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $398035.0 in 2021, then plummeted by 86.07% to $55441.0 in 2022, then soared by 617.94% to $398035.0 in 2023, then crashed by 68.17% to $126702.0 in 2024, then plummeted by 314.68% to -$272000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for CTSO at -$272000.0 in Q3 2025, $190635.0 in Q2 2025, and $190365.0 in Q1 2025.